Publicaciones en las que colabora con Rosa Bravo (13)

1997

  1. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 35, Núm. 3, pp. 225-230

  2. Co-infection with several HCV genotypes enhances liver damage in patients with chronic hepatitis C [3]

    Journal of Infection

  3. Lack of antiretroviral effect of alpha-interferon in HIV-infected patients treated for chronic hepatitis C [2]

    Journal of Infection

  4. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy [13]

    AIDS

1996

  1. Hepatitis C virus genotypes in different risk populations in Spain [4]

    Journal of Infectious Diseases

  2. Interferon α for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus

    Clinical Infectious Diseases, Vol. 23, Núm. 3, pp. 585-591

  3. Prevalencia de los genotipos del virus de la hepatitis C en drogadictos españoles con hepatitis crónica C

    Revista Clinica Espanola, Vol. 196, Núm. 10, pp. 673-677

  4. Propuesta de una escala de puntuación para decidir la opción terapéutica en la hepatitis crónica C en pacientes infectados por VIH

    Revista Clinica Espanola, Vol. 196, Núm. 7, pp. 488-491

  5. TRATAMIENTO DE LA HEPATITIS CRONICA C CON INTERFERON EN PACIENTES INFECTADOS POR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA

    Medicina Clinica, Vol. 106, Núm. 13, pp. 486-490

1995

  1. Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients

    Journal of Infection, Vol. 31, Núm. 1, pp. 9-13

  2. High rate of co-infection with different hepatitis C virus subtypes in HIV-infected intravenous drug addicts in Spain

    Journal of Hepatology, Vol. 22, Núm. 5, pp. 598-599

1994

  1. CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C [1]

    AIDS

1992

  1. Idiopathic CD4+ T-lymphocytopenia

    The Lancet